Sort   by:  
 Page size 
UnknownRandomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects.
Not available
S-EPMC8597139 | biostudies-literature
UnknownAmivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.
Not available
S-EPMC8791812 | biostudies-literature
UnknownAI is a viable alternative to high throughput screening: a 318-target study.
Not available
S-EPMC10987645 | biostudies-literature
UnknownHost-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology.
Not available
S-EPMC11931290 | biostudies-literature
UnknownTwo Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Not available
S-EPMC10794000 | biostudies-literature
UnknownThe contribution of de novo coding mutations to meningomyelocele.
Not available
S-EPMC12625549 | biostudies-literature
UnknownHost-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients.
Not available
S-EPMC11723965 | biostudies-literature
UnknownComprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume.
Not available
S-EPMC9213584 | biostudies-literature
UnknownCirculating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS.
Not available
S-EPMC12522733 | biostudies-literature
UnknownFeatures of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.
Not available
S-EPMC10764789 | biostudies-literature
Sort   by:  
 Page size